kabutan

Kidswell Bio, Last Fiscal Year's Operating Profit Unexpectedly Turns Profitable, The Current Fiscal Year's Operating Profit Turns to Loss

Tue May 13, 2025 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE Growth] announced its financial results after the market closed on May 13th (16:00). The consolidated operating profit/loss for the fiscal year ending March 2025 turned into a 0.02 billion yen, exceeding the forecast of a loss of 0.15 billion yen loss and turning an expected deficit into a profit. For the fiscal year ending March 2026, the consolidated operating profit/loss is projected to range from loss of 1 billion to loss of 1.7 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated operating profit/loss turned to a profit of 0.16 billion yen (compared to a loss of 0.66 billion yen in the previous period non-consolidated). The operating profit/loss margin drastically improved from -77.2% in the same period last year to 8.0%.

Note: Since the fiscal year ending March 2025, the company has transitioned to consolidated financial statements.

Note: In cases where performance forecasts are disclosed within a range, the article is created based on the midpoint of the range.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,776 -550 -624 -657 -20.8 0 May 12, 2023 J-GAAP
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 5,082 27 5 -21 -0.5 0 May 13, 2025 J-GAAP
YoY +109.0% － － +98.5% +98.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 4,900 -150 -200 -200 -4.9 0 Mar 31, 2025 J-GAAP
Mar, 2025 Results 5,082 27 5 -21 -0.5 0 May 13, 2025 J-GAAP
Revision Rate +3.7% － － +89.5% +89.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 1,749 -262 -267 -241 -6.1 0 Nov 12, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 5,082 27 5 -21 -0.5 0 May 13, 2025 J-GAAP
Mar, 2026 Guidance 5,250 -1,350 ー ー － 0 May 13, 2025 J-GAAP
YoY +3.3% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 865 -668 -677 -675 -19.1 -77.2 May 14, 2024 J-GAAP
Apr - Jun, 2024 482 -158 -176 -176 -4.5 -32.8 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 1,267 -104 -91 -65 -1.6 -8.2 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 1,287 125 106 54 1.4 9.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 2,046 164 166 166 4.1 8.0 May 13, 2025 J-GAAP
YoY +136.5% － － － －

Related Articles